STAT

Martin Shkreli has been sentenced. The drug industry is trying to get away scot-free

It's time for the biopharma industry to stop denying inconvenient truths, @adamfeuerstein writes
Martin Shkreli, center, with lead defense attorney Benjamin Brafman, right, at a news conference in New York in August.

On Friday, Martin Shkreli was sentenced to seven years in prison for his convictions on multiple counts of securities fraud — closing the book, for now, on the story of the drug executive who became one of the most despised people in the country.

, of course, gained notoriety for raising the price had nothing to do with that decision. But that has not stopped him from being a useful foil for pharma executives, who have done everything they can to distance themselves from the “Pharma Bro.”

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About A J&J Cough Syrup, A Pfizer And Moderna Patent Suit, And More
A Johnson & Johnson children’s cough syrup found to contain unsafe levels of a toxic industrial solvent was sold in six African countries.
STAT1 min read
USDA Faulted For Disclosing Scant Information About Outbreaks Of H5N1 Avian Flu In Cattle
With 28 herds in eight states infected with H5N1 bird flu, scientists are calling on the U.S. to release more data to help them assess the risk.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Lilly’s Zepbound For Sleep Apnea, The FDA Budget, And More
Eli Lilly reported positive results for Zepbound in obstructive sleep apnea, giving the medication a new edge in the highly competitive obesity market.

Related Books & Audiobooks